Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival. - Wikidata - wikimedia - TriplyDB

Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival.

Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival.

http://www.wikidata.org/entity/Q33516231

about

MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2 Clinical outcome prediction by microRNAs in human cancer: a systematic review Significance and therapeutic value of miRNAs in embryonal neural tumors Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles Transcriptional changes induced by the tumor dormancy-associated microRNA-190 Discovery and visualization of miRNA-mRNA functional modules within integrated data using bicluster analysis.miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples.Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma.Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastoma microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma New aspects of neuroblastoma treatment: ASPHO 2011 symposium review Co-localization of the oncogenic transcription factor MYCN and the DNA methyl binding protein MeCP2 at genomic sites in neuroblastoma.A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer.miRNA expression profiling of the murine TH-MYCN neuroblastoma model reveals similarities with human tumors and identifies novel candidate miRNAs MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma Environmental exposures in utero and microRNA.Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis.Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma Expressional alterations in functional ultra-conserved non-coding RNAs in response to all-trans retinoic acid--induced differentiation in neuroblastoma cells.miRNA Profiling: How to Bypass the Current Difficulties in the Diagnosis and Treatment of Sarcomas An Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma Chemoresistance Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients.MicroRNAs define distinct human neuroblastoma cell phenotypes and regulate their differentiation and tumorigenicity MicroRNA and DNA methylation alterations mediating retinoic acid induced neuroblastoma cell differentiation.Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma.MYCN-targeting miRNAs are predominantly downregulated during MYCN‑driven neuroblastoma tumor formation.MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway.Differential effects of substrate modulus on human vascular endothelial, smooth muscle, and fibroblastic cells Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis.High genomic instability predicts survival in metastatic high-risk neuroblastoma.Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs.Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death.miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity.MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1 MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas.MicroRNA-184-mediated inhibition of tumour growth in an orthotopic murine model of neuroblastoma miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells Epigenetic research in cancer epidemiology: trends, opportunities, and challenges Therapeutic targeting of miRNAs in neuroblastoma.

P2860

Q21245700-3E21E12A-F458-4192-9F01-AAA7D7AAA403 Q24289183-22983B08-2724-4E7D-991D-C39AC22EA772 Q26827171-335FE2C9-895A-449E-9247-E32408E0EEE8 Q27301841-0DDF34F5-B2A9-4DC3-8205-FFBE2C37F47B Q28383492-9B62E657-DD5E-4EBC-8EF7-C93D659F447D Q30571372-01EF37D5-0FA8-46C1-A5AB-44F3DDB3B0FD Q33559546-48656D57-4CED-412E-817A-F1851F5F726C Q33577733-2C662836-7992-4BE1-AF2D-9EFF2AE7F567 Q33891984-24B361FB-38F3-4FAB-BFDA-0E4A4CEAB21A Q33893064-9D0EC144-EED7-41C6-A48C-653E016FEF0E Q33922797-5A084C09-81AE-41BD-A031-6B89C7BC0D94 Q33952442-9A51333E-E04F-427C-8F50-91E352E08FC0 Q34049716-1C6B5DF3-3DC9-47E9-82C1-FF5DE16F4306 Q34099211-9CE82242-45B5-4E4E-98B8-EF357D230B40 Q34163789-8499AA9B-31D1-48AF-941A-12FAD859CF1A Q34252480-548A864E-D17C-470A-937D-BFF718EAAFD6 Q34254020-61D91E15-2D19-4C48-8848-5FB256E7C77A Q34533112-EEA9B806-5774-4D9F-922B-F9BE420CC19D Q34658931-2F6C4D55-2FE6-49BA-8F04-768368AB0932 Q34700668-D0422242-ECFD-4BAB-9103-60FFBFDFC7A5 Q34753903-91D7CB41-CCCC-412D-AAD9-A5B1804AD0DE Q35000508-22291982-746A-4256-A448-CFFDDB303EA5 Q35178612-7A39427A-3EC4-4B4F-9C3B-070FE1AB0C08 Q35510489-3D43CF7E-D9BB-4418-A978-186C22FA7DFE Q35620669-5FCA83C2-AE79-47B7-BCCE-5F95416886C4 Q35741642-13D36072-D655-497E-9C07-7258E85397FC Q35907425-A0C70F0B-4DE3-417A-991E-2336D8DDE649 Q35955696-052A279D-FCDD-40D2-9F42-643A9AD29742 Q35962195-584DC092-5875-45EF-B53B-7B364FD537A3 Q36282735-40E5D623-2AB6-4153-B093-4257738C4F12 Q36335774-DDC24CD2-E959-4CCA-83B6-CB01A0BAD2BE Q36361562-C237BB7C-8145-4B40-99E3-EB77198AF44E Q36544974-55D34210-AA80-4DC1-BD0F-47685CDF26B4 Q36766761-3922FA42-48C0-4104-898F-7D4A11B4DBAC Q36962575-5FB13039-262F-4CE0-ACF9-0758199DC8A5 Q37085930-A290FF3C-9084-4EA2-8267-A88E219E8461 Q37272173-BE4EB688-34AC-4CE3-BB60-C9BAE2B8F73A Q37581142-7B2897C0-CAE9-4855-839C-613FF3CE35E3 Q37587537-3CEC75CF-1498-40C6-B1EB-FFECEF0279E3 Q37775637-F2137D8E-286F-45DB-8CED-0754E021D649

P2860

Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival.

http://www.wikidata.org/entity/Q33516231

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Widespread dysregulation of Mi ...... iRNA expression with survival.

@ast

Widespread dysregulation of Mi ...... iRNA expression with survival.

@en

Widespread dysregulation of Mi ...... iRNA expression with survival.

@nl

type

label

Widespread dysregulation of Mi ...... iRNA expression with survival.

@ast

Widespread dysregulation of Mi ...... iRNA expression with survival.

@en

Widespread dysregulation of Mi ...... iRNA expression with survival.

@nl

prefLabel

Widespread dysregulation of Mi ...... iRNA expression with survival.

@ast

Widespread dysregulation of Mi ...... iRNA expression with survival.

@en

Widespread dysregulation of Mi ...... iRNA expression with survival.

@nl

P1433

Q33516231-D04F3362-EB86-4D77-918B-483AD9C094EB

P1476

Q33516231-537835E6-70D3-4A84-9EB2-31B1BD0BEAE4

P2093

Q33516231-1E80E9DF-7F73-4945-BE5D-CD1CE74BA434

Q33516231-3CEA8AD7-C8B0-4AE9-9796-FEB18BA7BE97

Q33516231-4522F645-E909-4DA5-83C3-BF60AFD516B2

Q33516231-6863B23D-AF5C-4D4B-9FB6-0C370940EB24

Q33516231-92676F5F-E981-41A5-AAAF-90C09C070E1E

Q33516231-98E63589-C85A-4566-8DA3-C00A115AB6ED

Q33516231-9F67D971-5C9D-4416-91A3-E280D07ABAF4

Q33516231-B50CD15C-59EB-46BC-A962-13B993EC9F5D

Q33516231-CD17F426-5373-464A-A6A9-3E68B779EA06

Q33516231-DE117C0E-36F9-4493-9AA2-AB1FAA63C57B

P2860

Q33516231-07F0DCD0-8E66-4C7F-A165-B2445066F015

Q33516231-0EB0087A-DBB5-45A8-B79F-2632B84FBED3

Q33516231-1090EA6C-1663-4B95-8F28-26D475F7DFBC

Q33516231-10BA2A7C-6601-4551-B79E-926C6F3134BC

Q33516231-2A4AC038-D63B-4AA5-B931-8487FB85F8C8

Q33516231-3CDCAEB1-42EC-479B-8E87-53FD475072DD

Q33516231-4E6EADF3-D3B2-47C9-9079-C776AC7C3059

Q33516231-72D69FD4-981F-4F9A-9C85-D29E5FE74CD6

Q33516231-741FE98E-088D-4688-B645-822E3C54644E

Q33516231-7480DF9B-8C05-4C0C-BB91-24354748F211

P304

Q33516231-CD933E34-B8D0-4ACC-BB79-7A8230EE14C9

P31

Q33516231-DEBA2DB2-77F2-4AD0-9BEC-2485BCDC26BC

P356

Q33516231-16B4A128-086C-4F3B-B997-D3B76064E2E8

P407

Q33516231-A29B4907-BACB-4C0B-A125-BD58C21CAC88

P433

Q33516231-48D0F45C-1412-4E08-B455-C46B7A962000

P478

Q33516231-FEB7EAB5-F5CE-4292-8B93-ABB3904FCA4C

P50

Q33516231-30FDFCC7-7BD2-48A1-BD96-8AB1DD9B8B3B

Q33516231-31A49537-571A-4203-B7DA-9D2F2AE0B921

Q33516231-3A18C521-8B9E-400F-BBCC-C5912D2B5A9A

Q33516231-99B1A661-42F2-4D7F-957F-C2567EB7ABBC

Q33516231-F202FDCB-8FDB-4319-8A0C-6E474731DE60

P577

Q33516231-7504B747-2F0F-41F4-95B0-A0059486504A

P5875

Q33516231-BABBF7AD-5280-4F39-89B6-7FE80C11F942

P698

Q33516231-701504D6-1275-472E-B0CB-9D8B7F434688

P921

Q33516231-8841A2A6-7BAF-4994-85C1-AFEDAA0395CB

P932

Q33516231-7F7EB3AB-D85F-43F6-B331-B37747B2C047

P356

JOURNAL.PONE.0007850

P1433

P1476

Widespread dysregulation of Mi ...... iRNA expression with survival.

@en

P2093

Anne O'Meara

http://www.w3.org/2001/XMLSchema#string

Derek M Murphy

http://www.w3.org/2001/XMLSchema#string

Isabella Bray

http://www.w3.org/2001/XMLSchema#string

Leah Alcock

http://www.w3.org/2001/XMLSchema#string

Niamh H Foley

http://www.w3.org/2001/XMLSchema#string

Patrick G Buckley

http://www.w3.org/2001/XMLSchema#string

Patrick W McGrady

http://www.w3.org/2001/XMLSchema#string

Pieter Mestdagh

http://www.w3.org/2001/XMLSchema#string

Raymond L Stallings

http://www.w3.org/2001/XMLSchema#string

Suzanne Prenter

http://www.w3.org/2001/XMLSchema#string

P2860

Microarray analysis of microRNA expression in the developing mammalian brain

Widespread microRNA repression by Myc contributes to tumorigenesis

Oncomirs - microRNAs with a role in cancer

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM

A novel and universal method for microRNA RT-qPCR data normalization.

Neuroblastoma: biological insights into a clinical enigma.

Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.

P304

e7850

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0007850

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Jo Vandesompele

Desmond G. Higgins

Maureen O'Sullivan

P577

2009-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38099963

http://www.w3.org/2001/XMLSchema#string

P698

19924232

http://www.w3.org/2001/XMLSchema#string

P921

microRNA expression

P932

2773120

http://www.w3.org/2001/XMLSchema#string